Psilocybin Stocks List

Psilocybin Stocks Recent News

Date Stock Title
Nov 5 CMPS Top 3 Health Care Stocks You'll Regret Missing In November
Nov 4 CMPS Compass Pathways: Phase 3 Trial Delay - Both Understandable And Disappointing
Nov 4 CMPS Compass Pathways: No Near-Term Fix For Struggling Psychedelic Therapy Pioneer
Nov 2 CMPS Compass Pathways cuts 30% of workforce on Phase 3 trial delays
Nov 1 CMPS Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity
Nov 1 CMPS Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
Nov 1 CMPS Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
Oct 31 CMPS COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript
Oct 31 CMPS Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
Oct 31 CMPS As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Oct 31 PBM Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
Oct 31 CMPS Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Oct 31 CMPS COMPASS Pathways falls after layoffs amid pipeline reset
Oct 31 CMPS Compass delays anticipated psilocybin readout, cuts staff
Oct 31 PBM Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
Oct 31 CMPS COMPASS Pathways ADS GAAP EPS of -$0.56 in-line
Oct 31 CMPS Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
Oct 30 CMPS Uncovering Potential: Compass Pathways's Earnings Preview
Oct 30 CMPS COMPASS Pathways ADS Q3 2024 Earnings Preview
Psilocybin

Psilocybin ( sy-lə-SY-bin, ) is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. The most potent are members of genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. Psilocybin is itself biologically inactive but is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of lysergic acid diethylamide (LSD), mescaline, and dimethyltryptamine (DMT). In general, the effects include euphoria, visual and mental hallucinations, changes in perception, distorted sense of time, and perceived spiritual experiences. It can also cause adverse reactions such as nausea and panic attacks.
Imagery found on cave paintings and rock art of modern-day Spain and Algeria suggests that human use of psilocybin mushrooms predates recorded history. In Mesoamerica, the mushrooms had long been consumed in spiritual and divinatory ceremonies before Spanish chroniclers first documented their use in the sixteenth century. In 1958, the Swiss chemist Albert Hofmann isolated psilocybin and psilocin from the mushroom Psilocybe mexicana. Hofmann's employer Sandoz marketed and sold pure psilocybin to physicians and clinicians worldwide for use in psychedelic therapy. Although the increasingly restrictive drug laws of the 1960s and the 1970s curbed scientific research into the effects of psilocybin and other hallucinogens, its popularity as an entheogen (spirituality-enhancing agent) grew in the next decade, owing largely to the increased availability of information on how to cultivate psilocybin mushrooms.
The intensity and duration of the effects of psilocybin are variable, depending on species or cultivar of mushrooms, dosage, individual physiology, and set and setting, as was shown in experiments led by Timothy Leary at Harvard University in the early 1960s. Once ingested, psilocybin is rapidly metabolized to psilocin, which then acts on serotonin receptors in the brain. The mind-altering effects of psilocybin typically last from two to six hours, although to individuals under the influence of psilocybin, the effects may seem to last much longer, since the drug can distort the perception of time. Possession of psilocybin-containing mushrooms has been outlawed in most countries, and psilocybin has been classified as a Schedule I controlled substance under the 1971 United Nations Convention on Psychotropic Substances.

Browse All Tags